These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5755927)

  • 1. [On the differences of effect of atropine, scopolamine and some of their quaternary derivatives after subcutaneous and enteral administration with special reference to scopolamine-n-butylbromide].
    Bauer R; Gross E; Scarselli V; Stockhaus K; Wick H
    Arzneimittelforschung; 1968 Sep; 18(9):1132-7. PubMed ID: 5755927
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the pharmacology and toxicology of the spasmolytic beta-diethyl-aminoethyl-(alpha-methyl-2,5-endomethylene-delta3-tetrahydrobenzhydryl)-ether-bromethylate].
    Brock N; Lenke D; Abel HH
    Arzneimittelforschung; 1967 Aug; 17(8):1005-12. PubMed ID: 4386143
    [No Abstract]   [Full Text] [Related]  

  • 3. [Testing of orally administered spasmolytics demonstrated by the effect of hyoscine-N-butylbromide on gastric motility].
    Schmid E; Bleichert A; Uberla K; Ritter U; Fehlhaber E
    Arzneimittelforschung; 1968 Nov; 18(11):1449-53. PubMed ID: 4885158
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the efficacy of oral hyoscine N-butyl bromide.
    Pennefather JN; McCulloch MW; Rand MJ
    J Pharm Pharmacol; 1968 Nov; 20(11):867-72. PubMed ID: 4387495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of small intestine motility by orally administered hyoscine-N-butylbromide].
    Schmid E; Bleichert A; Kitzing J; Ritter U
    Arzneimittelforschung; 1969 Jun; 19(6):998-9. PubMed ID: 5820047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibitory activities of several atropine-like drugs on the contraction of the digestive system and urinary bladder induced by the parasympathetic nerve stimulation in the dog].
    Kumada S; Otsuka M
    Nihon Yakurigaku Zasshi; 1970 Sep; 66(5):600-5. PubMed ID: 5529897
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of rectally applied hyoscin-N-butylbromide on small intestine motility].
    Schmid E; Ritter U
    Arzneimittelforschung; 1972 Dec; 22(12):2149. PubMed ID: 4679187
    [No Abstract]   [Full Text] [Related]  

  • 8. Spasmolytic activity of 3-tropanyl 2-(P-chlorophenyl) acrylate hydrochloride (SK & F 21000).
    Mehta RK; Shrivastava PN; Shrivastava DN
    Indian J Physiol Pharmacol; 1973; 17(1):83-6. PubMed ID: 4752056
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of prifinium bromide (1,1-diethyl-3-(diphenylmethylene)-2-methylpyrrolidium bromide) on the gastric antral motility in man.
    Kihara T; Ishihara Y; Ota A
    Arzneimittelforschung; 1970 Jun; 20(6):762-7. PubMed ID: 5468889
    [No Abstract]   [Full Text] [Related]  

  • 10. Human pharmacology of phentonium, a new autonomic drug.
    Azzollini F; Borgia M; Frigerio G; Lodola E; Monafo V; Porsio A
    Curr Ther Res Clin Exp; 1970 Nov; 12(11):734-54. PubMed ID: 4993127
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of gastric motility by rectal administration of hyoscine-N-butylbromide].
    Schmid E; Wagner T; Ritter U
    Arzneimittelforschung; 1971 Jun; 21(6):813-5. PubMed ID: 5109265
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological actions of timepidium bromide on the motility of visceral smooth muscles and the secretion of digestive juice in experimental animals (author's transl)].
    Tamaki H; Saito K
    Nihon Yakurigaku Zasshi; 1978 Jul; 74(5):559-71. PubMed ID: 700518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the ratio of equipotent oral and subcutaneous doses in man of prifinium bromide, a new synthetic spasmolytic.
    Kumada S; Kozatani J; Seki M
    Arzneimittelforschung; 1970 Feb; 20(2):237-40. PubMed ID: 5467469
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the pharmacology of the thymoleptic noxiptilin (Bay 1521)].
    Hoffmeister F; Wuttke W; Kroneberg G
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:846+. PubMed ID: 5819764
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrasonographic evaluation of reticular motility in cows after administration of atropine, scopolamine and xylazine.
    Braun U; Gansohr B; Haessig M
    J Vet Med A Physiol Pathol Clin Med; 2002 Aug; 49(6):299-302. PubMed ID: 12227472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of fucidin].
    Bykova MA; Storozhev IA; Berezina EK
    Antibiotiki; 1971 Mar; 16(3):216-7. PubMed ID: 5558682
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary bladder-selective action of the new antimuscarinic compound vamicamide.
    Oyasu H; Yamamoto T; Sato N; Sawada T; Ozaki R; Mukai T; Ozaki T; Nishii M; Sato H; Fujiwara T
    Arzneimittelforschung; 1994 Nov; 44(11):1242-9. PubMed ID: 7848339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin inhibits gastric emptying and small-intestinal transit in rats and dogs.
    Ruwart MJ; Rush BD
    Gastroenterology; 1984 Aug; 87(2):392-5. PubMed ID: 6376267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bradykinin on intestinal motility and blood flow.
    Fasth S; Hultén L
    Acta Chir Scand; 1973; 139(8):699-705. PubMed ID: 4770644
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the pharmacological action of phosphorylated pentaerythritol derivatives].
    Cheymol G
    Med Pharmacol Exp Int J Exp Med; 1965; 13(2):117-23. PubMed ID: 5897044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.